KETARx

KetaRx is a clinical-stage biopharmaceutical company focused on developing proprietary formulations of ketamine for various medical indications. The company's primary focus is on addressing the opioid crisis by providing non-opioid alternatives for post-operative pain management and treatments for opioid-induced respiratory depression. Additionally, KetaRx is exploring the use of its ketamine-based therapies for mental health conditions, including treatment-resistant depression and acute suicidal ideation. By leveraging the established anesthetic properties of ketamine in novel delivery formats, KetaRx aims to improve patient outcomes in both acute care and psychiatric settings.